Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Study to Evaluate the Safety and Efficacy of IVIG-F10 in Patients With Primary Immunodeficiency Diseases (PID)

NCT00168012 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00168012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Study to Evaluate the Safety and Efficacy of IVIG-F10 in Patients With Primary Immunodeficiency Diseases (PID)
Lead sponsor
CSL Behring
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2004
Completion date
September 30, 2005
Enrollment
42
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

agammaglobulinemia, common variable immunodeficiency, igg deficiency